The starting point and who it applies to
The short answer is yes: a prescription issued in one EU country is generally valid in every other EU country. This is one of the practical rights created by the EU cross-border healthcare framework. It lets a traveller, mobile worker, student or patient take a prescription to a pharmacy abroad without first obtaining a second prescription merely because a border was crossed. Recognition, however, is the start of the process—not a promise that every pharmacy can immediately supply and subsidise the product.
A cross-border prescription has no single mandatory EU form. It must instead contain enough standard information for a pharmacist to identify the patient, the prescriber and the treatment safely. Ask for the patient's full first name and surname and date of birth; the issue date; the prescriber's full name, professional qualification, work address and country, direct contact details and signature; and the medicine's common or active-substance name, pharmaceutical form, quantity, strength and dosage instructions.
The active substance matters more than the familiar brand. Brand names, pack sizes and manufacturers change between markets, while a pharmacy may stock an equivalent product under another name. Ask the prescriber to use the international or common name unless a medically justified branded product is necessary. Carry the original packaging or a current medicine list for context, but do not rely on a photograph of a box as a substitute for a valid prescription.
The pharmacy applies the law of the country where it dispenses the medicine. National rules can set a prescription's validity period, permitted quantity, repeat-dispensing conditions, substitution rules and special controls. A quantity routinely supplied at home may be limited abroad. A pharmacist can also pause or refuse dispensing if the prescription is incomplete, authenticity is doubtful, the medicine conflicts with local safety rules or the prescriber cannot be contacted to resolve a material question.
Availability is separate from legal recognition. A medicine may be authorised but not marketed in the destination country, temporarily out of stock, sold in a different strength or formulation, or available only through a hospital or specialist route. Even a centrally authorised medicine is not necessarily commercially available in every member state. Before travel, ask a pharmacy in the destination to check the active substance, strength and pack size; for essential treatment, discuss a safe contingency with the prescriber rather than improvising a substitute.
Electronic prescriptions are improving but are not yet a universal European wallet. MyHealth@EU connects participating national systems so an eligible ePrescription can be transferred electronically to a pharmacy in another participating country. The service depends on the issuing country, dispensing country, live connection, patient eligibility, medicine type and participating pharmacy. Check the Commission's current service map for the exact country pair; a country appearing somewhere in the network does not prove that every inbound and outbound route works.
Conditions and practical choices
Unless the current service is confirmed, request a printable cross-border prescription before departure. Even on a live MyHealth@EU route, a paper copy or other clinician-issued backup can help if a pharmacy is offline, the particular prescription is excluded or identity data do not match. Never print or alter an ePrescription yourself and present it as an original. The prescriber must issue the valid document, including a written or qualified digital signature where required.
At the pharmacy, carry official identification and the original prescription or use the authorised electronic route. Explain that it was issued in another EU country and allow time for checks. The pharmacist may need to identify the active substance, translate dosage instructions or contact the prescriber. If the requested product is unavailable, ask the pharmacist and prescriber—not an internet forum—to agree whether an equivalent strength, formulation or active substance is clinically appropriate.
Payment often surprises travellers. With a cross-border prescription you will usually be asked to pay the full pharmacy price upfront, even if the medicine is free or subsidised at home. Ask for an itemised receipt and keep the prescription or a copy accepted by the pharmacy. You may claim reimbursement from your home health insurer if the medicine is included in your home benefits, normally subject to the home system's rules and reimbursement ceiling. A refund is not automatic and may be lower than the amount paid.
The EHIC route is different. If medically necessary care arises during a temporary stay and a clinician in the country you are visiting issues a local prescription, present that prescription with your European Health Insurance Card. You should be treated under the same public-system conditions and charges as someone insured there. EHIC does not normally convert a prescription brought from home into a locally subsidised prescription, and it does not cover travel undertaken specifically to obtain medicine.
The EHIC guide explains necessary care during a temporary stay. The S1 guide covers people registered for healthcare where they live while another country remains responsible, and the S2 guide covers authorised planned treatment. A pharmacy purchase can touch any of these systems, so ask the responsible insurer which reimbursement route and documents apply to your actual situation.
Controlled, narcotic, psychotropic and otherwise restricted medicines require extra planning. Recognition of a prescription does not itself prove that you may carry the medicine across a border, possess the quantity in transit or have it dispensed abroad. National permits, Schengen certificates, medical letters, original packaging and quantity limits can apply. Check the health or medicines authority and customs guidance for every destination and transit country well before departure; do not assume that Schengen travel removes medicine controls.
Checks, limits and next steps
Some products sit outside the ordinary route. Hospital-only medicines, individually prepared products, medical devices, medicines requiring cold-chain handling and prescriptions reserved for particular specialists can trigger additional national conditions. A cross-border prescription also does not create a general EU right to order prescription-only medicine online. Online sale rules are national, and a website displaying an EU common logo must link to the relevant national register; use a physical licensed pharmacy when the legal or clinical route is uncertain.
If a pharmacy cannot dispense, first identify the reason. Missing information can be corrected by the original prescriber. A different brand may be resolved through the active substance. A stock problem may require another licensed pharmacy or a clinically approved alternative. A national legal restriction cannot be overridden by insisting that the prescription is European. Ask for the reason in writing when possible and contact the destination country's National Contact Point for cross-border healthcare if recognition appears to have been refused without a valid safety or legal basis.
Do not wait until the final dose to solve the problem. Before a longer stay, ask whether your home prescriber can lawfully provide enough medicine, whether monitoring or repeat prescriptions require a local clinician, and how refrigeration or transport must be handled. Carry medicines in labelled original packaging and keep them in hand luggage when permitted. Store the prescriber's contact details separately, and know the generic name, dose, allergies and important interactions in case urgent care is needed.
Language is manageable when the prescription is built correctly. EU rules focus on standard identifiers and the common name rather than requiring one European language. A pharmacist still needs to understand dosage and safety information, so ask for a clearly typed document and, for complex instructions, a clinician-prepared translation or medicine summary. Do not alter the prescription, and do not rely on an automatic translation for a dose that could be misunderstood.
Keep evidence for both care and reimbursement: the prescription, pharmacy receipt, product label, proof of payment, insurer correspondence and any refusal or substitution note. Submit the claim within your insurer's deadline and use its required form. If the insurer refuses, ask for the legal basis, calculation and appeal route. The home National Contact Point can explain cross-border healthcare rights; the destination National Contact Point can explain providers, national rules and complaint routes.
For Federal Europa, cross-border prescription recognition is a small but serious test of European citizenship. The common framework prevents a national border from automatically invalidating a clinician's prescription, while national pharmacists retain responsibility for safe dispensing and national health systems retain their own benefit rules. MyHealth@EU is gradually replacing paper with secure exchange, but responsible mobility still means checking the exact live connection, medicine, price and national controls rather than assuming one seamless database already exists.
The useful principle is recognition with safeguards. Europe has agreed on the minimum information that should travel, a route for electronic exchange and a basis for reimbursement. It has not made every national formulary, pharmacy price, controlled-drug rule or IT system identical. Prepare the prescription around the active substance, confirm availability, carry a legitimate backup, budget for upfront payment and keep the evidence. That turns a legal right into medicine safely received rather than a surprise at the pharmacy counter.